Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

67.57
+0.27000.40%
Post-market: 67.750.1800+0.27%19:44 EDT
Volume:6.22M
Turnover:423.07M
Market Cap:209.55B
PE:27.19
High:68.63
Open:68.04
Low:67.52
Close:67.30
Loading ...

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires Live
·
18 Mar

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer

Zacks
·
17 Mar

AstraZeneca's EsoBiotec Deal Seen as Logical -- Market Talk

Dow Jones
·
17 Mar

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies

Zacks
·
17 Mar

AstraZeneca (AZN) Gets a Buy from UBS

TIPRANKS
·
17 Mar

AstraZeneca to acquire EsoBiotec for $425M upfront

TIPRANKS
·
17 Mar

AstraZeneca Enters Deal to Acquire Cell Therapy Firm EsoBiotec for Up to $1 Billion

MT Newswires Live
·
17 Mar

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition

GlobeNewswire
·
17 Mar

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

Business Wire
·
15 Mar

Inovio Pharmaceuticals Reports Interim Trial Results of DNA-Encoded Monoclonal Antibodies for COVID-19

MT Newswires Live
·
14 Mar

AstraZeneca PLC ADR Outperforms Competitors On Strong Trading Day

Dow Jones
·
14 Mar

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
14 Mar

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live
·
13 Mar

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

Benzinga
·
13 Mar

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

Zacks
·
11 Mar

AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

Dow Jones
·
11 Mar

AstraZeneca PLC Stock Falls Monday, Outperforms Market

Dow Jones
·
11 Mar

Ionis Pharmaceuticals Says Transthyretin-Mediated Amyloidosis Treatment Gets Approval in Europe

MT Newswires Live
·
10 Mar

3 Top Cancer Biotechs to Keep An Eye On in 2025

Zacks
·
07 Mar

Astrazeneca Adjunctive Gastric Cancer Treatment Study Meets Primary Endpoint

MT Newswires Live
·
07 Mar